GLOBAL GENES
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$1,538,482
Receivables (Non-Related)
55%
Cash & Equivalents
36%
Prepaid Expenses
8%
Other Assets
<1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$1,351,107
Payables & Accruals
53%
Deferred Revenue
32%
Other Liabilities
14%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,409,145
$556,938
-60%
Receivables (Non-Related)
$466,406
$853,682
+83%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$194,808
$126,862
-35%
Investments
-
-
-
Property, Plant, & Equipment (net)
$0
$0
-
Other Assets
$28,781
$1,000
-97%
Total Assets
$2,099,140
$1,538,482
-27%
Liabilities
2023
2024
Change
Payables & Accruals
$804,996
$718,207
-11%
Grants Payable
-
-
-
Deferred Revenue
$645,000
$437,000
-32%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$191,407
$195,900
+2%
Total Liabilities
$1,641,403
$1,351,107
-18%
Net assets
2023
2024
Change
Restricted Net Assets
-
$1,505,689
-
Unrestricted Net Assets
$457,737
-$1,318,314
-388%
Net assets
2023
2024
Change
Net assets
+$457,737
+$187,375
-59%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)